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ABSTRACT
Background: Diabetic peripheral neuropathy (DPN) affects the lives of approximately
50% of all persons diagnosed with diabetes. Patients who are minorities, residents of
rural communities, low income, or non-compliant with treatment, have a higher risk of
developing DPN. The long-term effects interfere with the patient’s abilities to carry out
activities of daily living (ADLs) and instrumental activities of daily living (IADLs).
Patients incur debt from medical expenses, depression from the inability to perform selfcare, and became withdrawn because of their distorted body image.
Purpose: The purpose of this project was to use the Michigan Neuropathy Screening
Instrument (MNSI) scale to improve patient outcomes by promoting better identification
of individuals who need to be referred out to a specialist.
Design Methods: The patients were interviewed and surveyed using the Michigan
Neuropathy Screening Instrument (MNSI). After using the MNSI tool, patients were
evaluated for possible referral to podiatry and vascular specialty.
Conclusion: Results demonstrated the use of the MNSI tool improves the screening
process of patients diagnosed with diabetes reporting signs and symptoms of DPN.
Implications for Nursing: This project has the potential to improve patient quantality of
life, and lower cost to both patient and healthcare providers.

Keywords: diabetes mellitus 2, peripheral neuropathy, screening, prevention
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Preventing Complications of Undiagnosed Diabetic Peripheral Neuropathy in a Rural
Healthcare Settings
Introduction
Type 2 Diabetes Mellitus (T2DM) affects over 30 million people in the United
States of America (U.S.A.) (Jiwani et al., 2021). The strain to the healthcare system is
costly and impacts the quality of care distributed to all patients (Levy, 2021). Providers
are strained with thetask of seeing more patients in less time. In the rush of seeing
patients, quality measures are not being met. Yearly referrals for foot exams, vision
screenings, and glycated hemoglobin (A1cs) check are being missed (Anastasi & Klung,
2021). The patients are the ones who suffer from the lack of tracking their participation
in these gold standard screenings (Anastasi & Klung, 2021).
There is a shortage of healthcare providers, and the onboard training of new
providers is often not inclusive of all standard protocols (Magny-Normilus et al.,
2021). Due to the recent pandemic, staff meetings have been limited and quality
measures are not the priority. In previous years, all staff were included in quality
measures. This method allowed everyone to be informed and active from start to finish
within a patient encounter. For example, medical assistants (MA) often assisted the
provider in tracking patients annual screenings during the triage process (Anastasi &
Klung, 2021).
Prevention of peripheral neuropathy is an essential step in caring for the selfesteem in patients with T2DM (Hicks & Selvin, 2019). Foot ulcers are a risk in25% of
identified patients with diabetic peripheral neuropathy (DPN) (Hicks & Selvin, 2019).
These patients are then at higher risk for lower limb amputations, foot ulcers, chronic
pain, and an increase in mortality. The decline in motor function causes a decrease in
1

self-esteem and ability to complete activities of daily living (ADLs) (Parasoglou, Rao &
Slade, 2017). The effects of DPN causes impaired balance in majority of all patients
(Kukidome et al., 2017). In rural healthcare settings,transportation and financial
hardships can limit the number of times healthcare providers encounter their patients
diagnosed with diabetes.
Research has shown screening tools used specifically for DPN assist in achieving
better outcomes (Hershey, 2017). The purpose of this project was to use the scale to
improve patient outcomes by promoting better identification of individuals who need to
be referred out to a specialist (Fateh, Madani, Heshmat, & Larijani,2016).
Background
If one was able to prevent T2DM, then the complications, in turn, are also
prevented (Hoogendoorn et al.,2021). In this case, diabetic peripheral neuropathy (DPN)
was the focused complication. Studies have shown there are clinical implications prior to
the final diagnosis. Healthcare facilities would benefit from a system used to screen and
provide assess for early signs of DPN. This diagnosis results in increased cost for
patients, a decrease in their independence, and a decrease in patient self-esteem
(Hoogendoorn et al., 2021).
In a 2020 publication by Ahary, the researcher found compliance in T2DM
management was low, especially in women (Ahrary, 2020). Patients often suffer from
preventable complications of this disease. The responsibility of education and
implementation of early prevention lies in the hands of the healthcare team. When
patients were asked in routine visits of their last podiatric or visual screening, they were
unaware of the need. The observation of this lack of awareness of their basic care needs
raised a red flag. The increase of communication assisted patients of both genders with
2

diabetic compliance (Ahrary, 2020).
This DNP project was implemented to assist the rural community in early
detection of DPN (Levy, 2021). Studies show living in rural communities, belonging to a
minority group, or living below the poverty line, increase your mortality rate. This
project was conducted in two separate private practices. Each practice was enthusiastic
to participate in a quality improvement project which could result in better patient
outcomes. Both healthcare clinics had a high prevalence of diabetic patients with the
need of preventative care. Individuals in the participant group ranged from newly
diagnosed patients to those with very advanced cases of T2DM. Staff explored the
importance of early detection at a primary care level. Patients were assessed for this
project during regularly scheduled appointments. Levy (2021) suggested implementing a
screening into the normal triage process that would benefit both the patient and
healthcare quality measures.
Insurance providers hold insurers to a high standard of care (Chicharro-Luna et
al., 2020). Many organizations are reimbursed based on the percentage of quality
measures completed. Foot screening and diabetic eyes exams are a part of the quality
measures. Ensuring patients are compliant with each of these not only benefits the
patient, but increases financial reimbursement for the organization. This was not the sole
reason for this project, but it did offer an incentive (Chicharro-Luna et al.,2020).
The goal of this study was to maximize each patient encounter for individuals
with a diagnosis of T2DM in order to actively assist in maximizing their quality of life.
Research has shown providers should maximize contact time with each appointment
(Levy, 2021). This process did not inconvenience the participants, while still providing
them an improvement in care.
3

A study by Bauer et al., (2018) took into careful consideration a plan to
implement strategies to increase self-esteem in patients diagnosed with T2DM. Patients
identified as being diagnosed with T2DM were screened using the Michigan Neuropathy
Screening Instrument (see Appendix A) (MNSI, 2000).
Problem Statement
There is a need to identify and screen for diabetic peripheral neuropathy in
diabetic patient populations in rural healthcare settings. For this project, a needs
assessment revealed there was no protocol in place to identify DPN in patients on
scheduled visits. Facilities current practices resulted in providers treating signs and
symptoms as the patient brought it to their attention. Patients reported being unsatisfied
with their providers efforts to prevent future DPN complications. This project focused on
creating a screening policy for each patient with T2DM using the Michigan Neuropathy
Screening Instrument, the integration of this screening tool will encourage
patient/provider discussion which should result in earlier treatment (MNSI, 2000).
Obstacles that one encountered included provider and patient openness to change.
Transportation to and from scheduled appointments also proved difficult for indigent
patients. One project goal was to minimize the increase in patient triage times and oneon-one time with providers due to screening.
The PICO format is used to articulate questions to assist in Evidence Based
Practice (EBP) (Evidence Based Medicine, 2021). Using the PICO model helped outline
all elements deemed essential in this project. The model aided team members to support
the project presented. In rural patients previously diagnosed with diabetes mellitus (P)
how does being screened for diabetic peripheral neuropathy using the Michigan
Neuropathy Screening Instrument (MNSI) (I) compared to the same patients (C) prior to
4

screening, when addressing the rate of detection of peripheral neuropathy (O)
(Evidence Based Medicine,2021).

Organizational Description of Project Site
The project was conducted at two privately owned healthcare practice locations.
The two locations were rural practices where each provider sees on average 30 to 40
patients daily, respectively. The population consisted of patients diagnosed with diabetes,
hypertension, chronic pain, pulmonology, and peripheral neuropathy. The patient
employment ranged from retirees to adolescents entering college full-time.

Review of the Literature
The databases used most in this research were Cumulative Index to Nursing and
Allied Health Literature (CINAHL), PubMed, and BioMed Central. The search was
limited to scholarly articles published within the past five years. The following terms
which produced the most beneficial articles were DPN, diabetic foot ulcers, diabetic
vascular complications, and diabetic complications.
Hicks and Selvin (2019) conducted a quantitative study focused on the impact of
DPN and found that 50% of patients suffering with DPN will continue to develop further
complications. DPN cannot be reversed, and providers’ goal was to prevent and treat.The
authors found patient outcomes increased when patients maintained a desirable weight,
patiente education, increased physical activity, foot care, and pain control (Hicks &
Selvin, 2019).
The American Diabetes Association (ADA) recommended early prevention and
screening of DPN due to their review of cross-sectional data (Hicks &Selvin, 2019).
5

Ahrary, Khosravan, Alami, and Nesheli, (2020) conducted an individual randomized
controlled trial focusing on the effects of diabetic education in women. Hicks and Selvin
(2019) found patient education was an important preventative method in treating DPN.
Ahrary et al. (2020) comprised two trial groups totaling 115 participants. The trial group
(N=60) was given one-month close interventions with consistent in-person education
specific and appropriate for the group’s DPN diagnosis (Ahrary et al., 2020). There was a
significant decrease in the reporting of symptoms related to DPN.
Baurer et al. (2018) used increased technology to improve patient symptoms
related to DPN. The study randomized patients over six months to take part in a usual
care (UC) test. Patient demographics were balanced (N=62; 53% female, mean age = 63
years, 94% type 2 diabetes). Patients included in the test group reported increase in pain
threshold (Baurer et al., 2018). Text messaging was the chosen method of
communication and support to the patients identified. The text messages increased selfcare and education of T2DM for the patients (Baurer et al., 2018).
Hershey (2017) explored the comfort levels of clinical providers in recognizing
DPN in diabetic patients. The MNSI tool was used to explore its usefulness and accuracy
in screening patients. Using the MNSI tool helped identify asymptomatic patients with
DPN. Patients who were not identified early as suffering from DPN orT2DM were more
likely to have amputations. The article showed how important continuing education is for
all healthcare staff.
Hoogendoorn et al. (2020) shared similar ideology with Luciani et al. (2021) that
self-care improves the outcomes of those diagnoses with DPN. The exploration of
income, educational level, and personal determination helped predict the progression of
the disease process (Iqbal, 2018). Patients who were willing to learn proper dietary
6

requirements and measure their blood glucose levels were successful in a team approach
treatment plan. Having a basic knowledge of reportable signs and symptoms assists
providers in an outpatient care setting (Iqbal, 2018). Both articles agreed more studies are
needed relating to selfcare and responsibility.
Rodriguez et al. (2021) and Joo and Liu (2021) both took an interest in race as it
relates to T2DM. The data generated from these studies supports the hypothesis that
minorities are affected at a disproportionally higher rate than others. Unlike Rodriguez et
al. (2021), Joo and Liu (2021) believed in tailoring learning tools around the culture of
the audience being educated. Tools that include culturally considerate material are proven
to result in higher rates of acceptance (Joo & Liu, 2021). DPN caused progressive nerve
damage which results in amputations in some patients. Patients may also experience pain
and paresthesia (Hershey, 2017). The tool can be used in all patients at high risk for nerve
damage.
Hershey (2017) investigated depression, amputation risk, sleep disturbances, and
chronic pain patients often report to their providers. The MNSI was the gold standard for
early detection. The tool had two parts. There was a questionnaire and exam to be
performed during this proposal. The patient’s history was assessed with 15 questions that
was answered using ‘yes’ or ‘no’ (Hershey, 2017). The examination was conducted by
examining: (a) appearance (b)ulceration (c) ankle reflexes (d) vibration sensation at the
great toe, and (e) monofilament exam (Hershey, 2017). For purposes of this DNP project,
onlythe questionnaire was used for data collection for ethical considerations for the
patients.
As part of their routine exam, the assessment was also completed but was not
used for data collection in the project.
7

Evidence-Based Practice: Verification of Chosen Option
The MNSI is considered the gold standard for early detection of DPN (Hershey,
2017). The tool has two parts involving a questionnaire and exam to be performed during
this proposal. For purposes of this DNP project, only the questionnaire was used for data
collection for ethical considerations for the patients. As part of their routine exam, the
assessment was also completed but was not used for data collection in the project.

Theoretical Framework/Evidence-Based Practice Model
The framework model utilized for this project was the Iowa model (Cullen et al.,
2019). This model was developed by members of the Iowa University system and allows
for practitioners to bridge the gap between research and practice using an evidence-based
approach. An organized project design is needed to assist one in furthering the nursing
profession.
The model provides practitioners with a method of project development and
implementation and utilizes a template to guide researchers from the start to finish on
their project (Cullen et al., 2019). Identifying problem-focused or knowledge-focused
triggers is step one of using the model. In the case of this project, the PICO is
categorized as ‘Process Improvement Data’. The need to identify early signs and
symptoms of DPN is important to prevent costly outcomes for patients and the
healthcare system (Cullen et al., 2019).
Topics not categorized as priority are not recommended per the Iowa model
(Cullen et al., 2019). The model encourages the writer to confront more challenging
topics. Once the topic is formed, a team is organized. One is encouraged to formulate a
8

team in which each participant can contribute to the outcome of the project. A team
should encompass personnel of all skill sets and educational levels. Staff employed
individuals in different positions have perspectives which can benefit the results of the
study (Cullen et al., 2019).
Literature is reviewed to find out if the project is supported by research (Cullen et
al., 2019). If one uses the Iowa model, it allows early identification of a project that is not
well researched. Without this template, one would waste valuable time on a project that
would not yield results. Time is important when addressing quality improvement tasks.
The project will then move into the implementation stage (Cullen et al., 2019).
After careful organization of the data, the decision to apply the data should be
made by the team (Cullen et al., 2019). The leadership team will monitor the project
from start to finish, while ensuring to review feedback of the participants and staff.
There are often barriers that cannot be predicted during the planning process. If the
project is to be repeated, correcting errors each time will allow for smoother execution.
The Iowa model is useful in organizing a project from beginning to end (Cullen et al.,
2019).

Goals, Objectives, and Expected Outcomes
The purpose of this project was to use the Michigan Neuropathy Screening
Instrument (MNSI) scale to improve patient outcomes by promoting better identification
of individuals who need to be referred out to a specialist.
The goals and expected outcomes were:
•

The first section of the MNSI tool will be completed on all qualifying
patients who consent, during regularly scheduled patient appointments.
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•

There will be a goal of 12-13 MNSI exams within a 2-week period.

•

This implementation will occur during scheduled appointments as a
component of the normal assessment. There was no financial incentive for
participation. However, the possibility for improved quality of life is the
ultimate goal for patients. The staff at both facilities have generously
agreed to volunteer their time.

•

The goal of both facilities is to identify patients at high risk of
experiencing complications of T2DM specifically related to
DPN.

•

The MNSI tools should only add an additional 20-30 minutes to
the patient’s total treatment time. The project data was able to
be completed in approximately three months’ time.

Project Design
The project design was a quality improvement (QI) project. It will assist in
developing a health policy to detect signs of peripheral neuropathy in patients within two
rural facilities. The QI project was a quasi-experimental design using purposive sampling
from two clinical sites. The project consisted of short yes or no answer questions which
will be asked verbally to patients by healthcare providers trained on the use of the tool.
The data was used to show the percent of patients without a prior diagnosis of peripheral
neuropathy who were identified as high risk using the MNSI scale. The screening added
approximately five minutes to each visit.
Project Site and Population
10

Diabetic peripheral neuropathy costs the United States (U.S.) $10.9 billion per
year in healthcare (Hershey, 2017). DPN is typically under-reported and under- treated,
adding a burden to an already vulnerable population (Hershey, 2017). The chosen clinical
sites were home to an abundant number of diabetic patients who lived in rural
communities. The sites were considered rural, due to the level of economic and
healthcare services available. “Site A” had two medical doctors and two nurse
practitioners. “Site B” had four vascular surgeons and one nurse practitioner. The patients
seen daily ranged from approximately 90-120 patients collectively among providers at
each site. Among the patients seen, roughly 30% were diagnosed with T2DM.
Diabetes is ranked Alabama’s ninth health concern (Alabama, 2019). During the
project phase, the population surrounding “Site A”’ was 35,957 (U.S. Census Bureau,
2019). Women made up 51.1% of that population; 14.9% of the people in the area were
age 65 and older (U.S. Census Bureau, 2019). The majority of the population’s race was
Caucasian and made up 75.8%, while African Americans made up 18.7% (U.S. Census
Bureau, 2019). The remaining races were a mixture of American Indian and Alaska
Native alone, Asian alone, Native Hawaiian and Other Pacific Islander alone, Hispanic
or Latino, and two or more races, (U.S. Census Bureau, 2019).
The median value of owner-occupied housing was $162,700 (U.S. Census
Bureau, 2019). There were 14,069 households, which averages out to be approximately
2.5 people per home. The median household income was $61,110. Thirteen point one
percent of the population were under the age of 65 with a disability, and there were 7.9%
of individuals without health insurance under the age of 65. The poverty level was
15.9% (U.S. Census Bureau,2019).
The population surrounding “Site B” was 226,486 (U.S. Census Bureau, 2019).
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Women made up 53% of that population. A small percentage, 15.6%, of the people in the
area were age 65 and older. The majority of the population’s race was White alone and
made up 35.5%, while Black or African Americans made up 59.3%. The remaining races
were a mixture of American Indian and Alaska Native alone, Asian alone, Native
Hawaiian and Other Pacific Islander alone, Hispanic or Latino and two or more races,
(U.S. CensusBureau, 2019).
The median value of owner-occupied housing was $129,800 (U.S. Census
Bureau, 2019). There were 89,527 households, which averages out to be approximately
2.46 people per home. The median household income was $50,124. A reported 11.7% of
the population were under the age of 65 with a disability and there were 12.2% without
health insurance under the age of 65. The poverty level was at 15.8%, (U.S. Census
Bureau, 2019).
Setting Facilitators and Barriers
Conducting projects at two sites could have led to complications in
implementation. Rural patients live, on average, more than 30 minutes from the two
clinical sites used in this project. Many of the participants are transported to their routine
appointments by a family member or close friend. This often leaves patients feeling
rushed. This distance often causes patients to miss their scheduled appointments.
Patients who were illiterate may not have understood questions asked by the screeners.
There are staff members who may have reservations of the DNP project, and see this
and an unnecessary task.
Implementation Plan/Procedures
The author created a PowerPoint with voiceover that explained the process of the
study. The officer manager at each site assisted with identifying up to six staff members
12

for training. After the staff members volunteered, the training was scheduled at their
convenience. The PowerPoint covered the complete process and allowed for questions.
The staff members had the contact information of the project coordinators for all
inquiries.
Staff members were provided a copy of steps of the implementation. The staff
assisted primarily with gaining consent and distributing and collecting the MNSI tool.
The providers conducted the assessment portion which completes the tool. Patients were
educated about their right to confidentiality, privacy, and that they could opt out at any
time and their information would not be used. A demographic form (see appendix B) was
also used, and data was coded. The participants were assigned a designated number. That
number was used on the demographic form where data were collected. The patient may
have experienced minimal distress when they learned of the need for a referral to a
specialist depending on the findings of the survey. Confidentiality was also protected.
Personal information was redacted from all study forms prior to data analysis.
Participants were only identified with numbers. A form containing information linking
names to numbers was kept on a password protected computer in the PI's office and
will be destroyed 3 years after study completion. The project was implemented on
November 9th, 2020 and continued until February 17th, 2021. A total of 31
participants were interviewed.
Measurement Instruments
In order to measure the outcomes of this DNP project, the MNSI instrument was
used. The MNSI tool can be found in Appendix A. This instrument was used with
permission and it specifically addressed the peripheral neuropathy that could be
undetected at times in the diabetic patient.
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The MNSI has become a part of the triaging process of all patients with a
diagnosis of T2DM. The history was completed with the nurse prior to the clinical
providerentering the room. After the patient completed the history, the nurse helped
remove the patient’s shoes and socks with their permission. The provider then conducted
the physicalexam on the patient as part of their routine care. If deficits were found, the
patient was referred to the appropriate specialist to carry out additional diagnostic exams.
Data Collection Procedures
The patients entered the triage room as they typically do upon a visit. The author
reviewed all paperwork with participants. This ensured all guidelines were followed per
the IRB’s standard. After informed consent was obtained, the MNSI survey was
administered. The feedback was immediate, and the patient was advised of the
recommendations.
Data Analysis
A professional statistician was hired to review all data produced in this project. A
Bayesian analysis was used to analyze the data collected in this quality improvement
project. The analysis was broken down by race, gender, age, and site locations. The
participants were sent to podiatry and vascular specialist if the MNSI tool called for a
more detailed look for the interest of the patient’s quality of care. The use of a statistician
ensured the quality of the calculations of datum collected in this project. A Bayesian
approach is appropriate for this study because it provides ratio estimates regarding two
differing hypotheses. It is also helpful with analyzing observed data as opposed to
unobserved quantities (Hackenberger, 2019).
The data showed 84% of participants needed podiatry referrals and 44% required
vascular consults. This was a key finding as diabetic patients are recommended to have
14

annual podiatric visits to increase their quality of care. The analysis reported African
American participants were referred to a vascular specialist with a mean of 0.47 and
standard deviation (SD) of 0.11. The Caucasian population’s vascular referral rate was
0.44 with a SD of 0.12. This yielded a mean difference of 0.03 and showed no significant
differences among races for vascular referrals. Podiatry referrals in African American
participants had a mean of 0.82 with a SD of 0.09 and Caucasian participants were 0.79
with SD of 0.10. Again, there was a mean difference 0.03 with a SD of 0.13 difference
thats showed both races were fairly equal (see Appendix C).
Age was another variable that was important to analyze in this project. The age of
the participants ranged from 40-70s. Mean vascular referrals for participants in their 40s
were reported at 0.44 with a SD of 0.17, 70-year-old participants’ mean was 0.39 with a
SD 0.13. The mean was higher in patients in their 50- and 60-year age range. There were
mean differences seen in podiatry referrals. There was no pattern seen related to age. The
mean was reported above 0.50 for patients in all reported age participants (see Appendix
D).
Male participants needed vascular consults at a significantly higher rate than
female participants. The mean for males was 0.64 with a SD of 0.12 and female was
0.34 with a SD of 0.10 (see Appendix E). This is a mean difference of -0.30 and SD
0.16. This is a credible difference statistically. The podiatry means were high for both
genders. The female means were 0.84 with a SD of 0.08 a mean of 0.77 for males and
SD of 0.11 with a mean difference between genders was 0.07 with a SD of 0.13.
Using the MNSI tool helped identify patients in need of specialty care who
would have otherwise been overlooked.
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Results
There were two rural facilities studied in this project. The ability to compare two
sites allowed for in depth comparison of patient type. The “Site A”’ vascular referrals
hada mean of 0.35 and SD of 0.09; “Site B” vascular referrals had a mean of 0.75 and a
SD of 0.13. There was a statistically significant mean difference of -0.40 with a SD of
0.16. This type of QI data is important, due to improvements that can be made for the
sake of the patients. The podiatry referrals needed were high and similar at both
facilities. “Site A”’ mean was 0.83 with a SD of 0.07, “Site B”; mean was 0.75 with a
SD of 0.13. The difference mean was 0.08 with a SD of 0.15 (see Appendix F).

Interpretation/ Discussion
Some of the data yielded from this project was statistically significant. Due to
implementing the DNP project as written, patients were able to receive real-time
feedback. A total of 84% of participants were sent to a podiatrist and educated on yearly
podiatric exams. Another 44% of participants showed concerning signs and symptoms
that permitted an immediate vascular referral. The leadership team was able togather
pertinent feedback to assist in the future operations of their practice.
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Male patients have a significantly higher rate of unnoticed complications of
T2DM. It is recommended that providers educate the staff and screen the population
closer, to improve their quality care. The primary care practice also had a significantly
higher rateof patients who had been overlooked for early signs and symptoms of DPN.
This data supports the use of the MNSI tool in the primary care setting to prevent
patients suffering preventable complications.

Cost-Benefit Analysis/Budget
Clinical sites A and B did not have to operate outside of their normal office hours
to accommodate the project. There was no cost to conduct the experiment at the two
designated sites. The employees at “Site A” and “ Site B” volunteered their time to assist
with the quality improvement project. Each clinical site assigned individuals who would
be briefed to conduct the survey during the normal triaging period. Patients were not
financially compensated but were provided screening to improve their quality of life.
It is recommended to use the screening tools during the patients triage process.
The tool is provided free via the internet. Quality measures require that the necessary
tools are used during each patient encounter. Each facility offered their sites free of cost.
Timeline
The timeline for the project followed the model (Appendix G). The timeline takes
into consideration the project due date and personnel involved. There was leniency in
adjustments, but great effort was given to adhere to the timeline for planning phase,
implementation phase, and data analysis phase. Consideration was given to the normal
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operating practice of the two facilities. The project was modeled in that it could be
implemented during regular patient visits.
Ethical Considerations/Protection of Human Subjects
The Jacksonville State University Institutional Review Board (IRB) (see
Appendix H) approval was obtained before initiating the DNP project. Permission to use
the MNSI tool was obtained (see Appendix I) prior to use. Permission to conduct the
project at the locations was also obtained (see Appendix J). There was minimal risk
associated with this project. The patients who volunteered to participate were ensured
their demographic data will be used only for the sake of the project. Informed consent
was obtained prior to screening (see Appendix K).
One benefit to the institutions was gaining a systematic approach to screen for
(DPN). This project will assist in preventing unforeseen complications of T2DM.
Patients will benefit from a screening that may assist in improving the quality and length
of life. The information received could be used to improve the quality-of-care patients
receive at each location. The patient can have an increased sense of protection knowing
their provider was allowing forward thinking research in their office. Patients who
volunteered had the potential for a better quality of life and earlier detection.
Conclusion
The MNSI tool improves the screening process of patients diagnosed with
diabetes reporting signs and symptoms of DPN. Each of the facilities recognized the
increase of patients identified early for DPN which improved quality care and adherence
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to the gold standards of diabetes. Many of the participants reported contributing
symptoms to their age not their diabetic diagnosis. The strength of this QI project is that
it took minimum time for the patients and staff to complete, improved patient-provider
trust, and has the potential to improved quality of life for the patient. The completion of
the project sparked the interest of the staff and providers of surrounding healthcare
facilities. This interest made the implementation of the project easy for those involved.
The recommendation is to follow the model used in this project, screening with the
MNSI tool during regularly scheduled visits. The MNSI tool has proven to be highly
effective in recognizing early symptoms of DPN in patients who do not recognize
common signs and symptoms. The wording of the tool was phrased in a way that patients
of all educational levels understood the questions being asked in the tool. The use of this
tool has the potential to save a significant amount of money for healthcare clinics,
hospitals, and patients annually. It is recommended that further QI projects are
preformed to increase the quality-of-care patients diagnosed with diabetes living in rural
healthcare are receiving. This DNP project would benefit the inner cities, underserved,
and lower income communities.
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APPENDIX B
Demographic Information
Identifying Number:
Gender: M/F/T/A
Age:
Race or Self-Identified Cultural Background:
Years of Diagnosis of Diabetes:
Smoker: Y/N

years smoked

HTN: Y/N Hyperlipidemia: Y/N
Podiatrist Y/N Last Visit
Reason for today’s appointment
Diabetic Medications patient prescribed/Duration:

Treatment
Action

Vascular Referral: Y/N
Podiatrist Referral: Y/N
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APPENDIX C

Bayesian Analysis

Difference in Race variable

B_VR_p
W_VR_p
Diff_VR_p
B_PR_p
W_PR_p
Diff_PR_p

mean
0.47
0.44
0.03
0.82
0.79
0.03

sd
0.11
0.12
0.16
0.09
0.10
0.13

5.5%
0.30
0.26
-0.23
0.67
0.61
-0.17

94.5%
0.65
0.64
0.29
0.93
0.92
0.24

All the credible intervals contain zero which means the difference values are plausibly zero.
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APPENDIX D
Difference in Age range (by decade) variable

40s_VR_p
50s_VR_p
60s_VR_p
70s_VR_p
40s_PR_p
50s_PR_p
60s_PR_p
70s_PR_p

mean
0.44
0.50
0.53
0.39
0.69
0.50
0.78
0.88

sd
0.17
0.21
0.12
0.13
0.16
0.21
0.10
0.09

5.5%
0.18
0.16
0.33
0.20
0.40
0.16
0.59
0.71

94.5%
0.72
0.84
0.72
0.61
0.90
0.84
0.92
0.97

All the credible intervals overlap which means the difference values are plausibly zero.
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APPENDIX E

Difference in Gender variable

F_VR_p
M_VR_p
Diff_VR_p
F_PR_p
M_PR_p
Diff_PR_p

mean
0.34
0.64
-0.30
0.84
0.77
0.07

sd
5.5%
0.10 0.19
0.12 0.43
0.16 -0.54
0.08
0.69
0.11
0.57
0.13 -0.13

94.5%
0.51
0.82
-0.03
0.94
0.91
0.30

The credible interval does not contain zero which means the difference values are plausibly different (statistically
significant)
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APPENDIX F

Difference in Site location variable

A_VR_p
B_VR_p
Diff_VR_p
A_PR_p
B_PR_p
Diff_PR_p

mean
0.35
0.75
-0.40
0.83
0.75
0.08

sd
0.09
0.13
0.16
0.07
0.13
0.15

5.5%
0.21
0.50
-0.63
0.70
0.50
-0.14

94.5%
0.51
0.92
-0.12
0.93
0.92
0.35

The credible interval does not contain zero which means the difference values are plausibly different (statistically
significant).
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APPENDIX G
Timeline
DNP Project Timeline
Task
Recruitment

October November December January February March April
X

X

X

X

X

X

X

X

X

X

X

of eligible
participants
Intervention:
Evaluation;
Toolkit
Post-test and

X

X

Analysis of
outcomes
Results

X

presented to
local
providers
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APPENDIX H
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APPENDIX I
Michigan Neuropathy Screening Instrument Consent

RE: DNP student seeking permission to use MNSI tool
Campbell, Pam <pamcamp@med.umich.edu>
Sat 9/26/2020 7:37 AM
To:

•

Kendra Ward Harris <kwardharris@stu.jsu.edu>

Dear Ms. Harris,
Please feel free to use our MNSI survey instrument. We just ask that you please cite our Center
as follows: The project described was supported by Grant Number P30DK020572 (MDRC) from
the National Institute of Diabetes and Digestive and Kidney Diseases.
Thank you,
Pam Campbell
Michigan Diabetes Research Center
Michigan Center for Diabetes Translational Research
University of Michigan Medical School
1000 Wall Street
RM# 6100 Brehm Tower
Ann Arbor, Michigan 48105
Tel: 734-763-5730
Fax: 734-647-2307
Remember to cite the Michigan Diabetes Research Center (MDRC) and/or the Michigan Center
for Diabetes Translational Research (MCDTR) in publications:
"The project described was supported by Grant Number P30DK020572 (MDRC) from the
National Institute of Diabetes and Digestive and Kidney Diseases" OR the project described was
supported by Grant Number P30DK092926 (MCDTR) from the National Institute of Diabetes and
Digestive and Kidney Diseases.”
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APPENDIX J
Agency Letters
A.

MedicalcareAssociates
PRATIVILLE

To Whom It May Concern:
I, Kendra Ward Harris, MSN, RN, FNP-C, a Doctor of Nursing Practice (DNP) student at
Jacksonville State University has permission to conduct a Quality Improvement DNP project
titled: Preventing Complications of Undiagnosed Diabetic Peripheral Neuropathy in a Rural
Healthcare Settings. This DNP project will be conducted at 102 Medical Center Dr. Prattville Al,
36066.

Derrick Brown, JD
CEO

12052532205

attydbrown@gmail.com
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B.
ROBERT E. ENGLES, JR., MD, FACS
RALPH B. REDD, MD, FACS
BENJAMIN T. RUSH, DO
JONATHAN CUDNIK, MD
2055 East South Boulevard, Suite 908
Montgomery, Alabama 36116
(334) 284-6500 - Office
(334) 284-6202 - Fax
www.montgomeryvascular.com

September 29, 2020

To Whom It May Concern:

I ,Kendra Ward Harris, MSN, RN, FNP-C, a Doctor of Nursing Practice (DNP) student at Jacksonville State
University has permission to conduct a Quality Improvement DNP project titled: Preventing Complications of
Undiagnosed Diabetic Peripheral Neuropathy in a Rural Healthcare Settings. This DNP project may be
conducted at 2055 E South Blvd #908, Montgomery, AL 36116.

Vascular Surgeon, Co-owner
334-284-6500
rbreddmd@yahoo.com
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APPENDIX K
CONSENT FOR PARTICIPATION IN A STUDY
Title of Project: “Preventing Complications of Undiagnosed Diabetic Peripheral
Neuropathy in Rural Healthcare Settings”
Investigator Names: Kendra Ward Harris & Laura E. Barrow E-Mail Contact
Information: kwardharris@stu.jsu.edu , lbarrow@jsu.edu
You are being asked to participate in a research study. Before you give your consent to
volunteer, it is important that you read the following information and ask as many
questions as necessary to be sure you understand what you are being asked to do.
Investigators
Kendra Ward Harris, MSN, CRNP, FNP-C
Laura E. Barrow, PhD, RN
Purpose of the Research
This project identifies patients with diabetes mellitus 2 who unknowingly suffer with
diabetic peripheral neuropathy. Identifying the early onset of disease in a rural healthcare
setting, during subsequent healthcare visits. The patients will become educated and
referred to the proper specialist to slow the progression of the disease. The early
screening will allow one to prevent the consequences of untreated diabetic peripheral
neuropathy.
Procedures
If you volunteer to participate in this study, you will be asked to respond to questions
asked in a semi-structured interview. Questions will be focused on personal symptoms
you experience with diabetes mellitus 2. Your participation will consist of participating in
one interview taking approximately 45 minutes.
Potential Risks or Discomforts
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There are no foreseeable risks, however, participants may experience positive or negative
feelings that may be experienced as they respond to questions or when reflecting onto the
interview. The interview will be conducted at the patient’s regularly scheduled chronic
care appointment. There are no costs associated with your participation in the study. You
have the right to discontinue participation, temporarily or permanently, without any
consequence.
Potential Benefits of the Research
There are personal benefits for patients participating in the study. The patients with
participation will identify early signs diabetic peripheral neuropathy (DPN). The nursing
profession and clinical practice standards will increase due to the knowledge obtained in
this study.
Confidentiality and Data Storage
Identifying information will be confidential and not be shared with anyone. You will be
asked to select a pseudonym, unrelated to your name, which will be used during your
interview, on all transcriptions and notes and journaling, and your demographic
datasheet. Your demographic datasheet will be kept in a locked location, separate from
audio recordings and transcriptions. Your name will not be used in discussion with others
regarding this research. If any identifying information is mentioned during your
interview, that will be redacted from the written transcript and replaced with an
alternative pseudonym. Other than any information that is redacted to protect the
confidentiality, the interview will be transcribed verbatim.
Data will be stored in the researchers’ offices on a password-protected computer. Only
the researchers will have access to the surveys. Following the completion of the project,
the surveys will be destroyed six months after the study.
Questions, Participation, and Withdrawal
Your participation in this research study is voluntary. As a participant, you may refuse to
participate at any time. To withdraw from the study please contact the researchers at 334333-6544, 256-490-3625, kwardharris@stu.jsu.edu , or lbarrow@jsu.edu.
Reasons for Exclusion from this Study
The exclusion criteria for this study include the inability to speak English or no diagnosis
of diabetes mellitus 2.

Signature of Research Participant

Date
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Participant Name (Please Print)

Date

Signature of Person Obtaining Consent

Date

3038

